Centerpoint Advisors’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $66K | Buy |
697
+233
| +50% | +$22.2K | 0.02% | 152 |
|
|
2026
Q2 | $39K | Hold |
464
| – | – | 0.01% | 188 |
|
|
2026
Q1 | $33K | Hold |
464
| – | – | 0.01% | 178 |
|
|
2025
Q4 | $37K | Buy |
464
+323
| +229% | +$25.6K | 0.01% | 180 |
|
|
2025
Q3 | $12K | Hold |
141
| – | – | ﹤0.01% | 320 |
|
|
2025
Q2 | $11K | Hold |
141
| – | – | ﹤0.01% | 305 |
|
|
2025
Q1 | $11K | Hold |
141
| – | – | ﹤0.01% | 315 |
|
|
2024
Q4 | $12K | Sell |
141
-314
| -69% | -$26.1K | ﹤0.01% | 335 |
|
|
2024
Q3 | $38K | Hold |
455
| – | – | 0.01% | 195 |
|
|
2024
Q2 | $32K | Sell |
455
-80
| -15% | -$5.71K | 0.01% | 213 |
|
|
2024
Q1 | $40K | Hold |
535
| – | – | 0.02% | 185 |
|
|
2023
Q4 | $35K | Sell |
535
-361
| -40% | -$22.6K | 0.01% | 180 |
|
|
2023
Q3 | $56K | Buy |
896
+361
| +67% | +$22.5K | 0.02% | 146 |
|
|
2023
Q2 | $30K | Hold |
535
| – | – | 0.01% | 204 |
|
|
2023
Q1 | $31K | Hold |
535
| – | – | 0.01% | 204 |
|
|
2022
Q4 | $39K | Hold |
535
| – | – | 0.02% | 159 |
|
|
2022
Q3 | $33K | Hold |
535
| – | – | 0.02% | 156 |
|
|
2022
Q2 | $34K | Hold |
535
| – | – | 0.02% | 163 |
|
|
2022
Q1 | $38K | Hold |
535
| – | – | 0.02% | 164 |
|
|
2021
Q4 | $33K | Hold |
535
| – | – | 0.01% | 151 |
|
|
2021
Q3 | $33K | Hold |
535
| – | – | 0.02% | 144 |
|
|
2021
Q2 | $32K | Sell |
535
-41
| -7% | -$2.6K | 0.02% | 148 |
|
|
2021
Q1 | $35K | Hold |
576
| – | – | 0.02% | 116 |
|
|
2020
Q4 | $27K | Buy |
576
+1
| +0.2% | +$43 | 0.02% | 122 |
|
|
2020
Q3 | $21K | Hold |
575
| – | – | 0.02% | 119 |
|
|
2020
Q2 | $21K | Hold |
575
| – | – | 0.02% | 121 |
|
|
2020
Q1 | $18K | Buy |
575
+1
| +0.2% | +$44 | 0.02% | 121 |
|
|
2019
Q4 | $29K | Buy |
574
+39
| +7% | +$1.88K | 0.02% | 126 |
|
|
2019
Q3 | $25K | Hold |
535
| – | – | 0.02% | 122 |
|
|
2019
Q2 | $27K | Hold |
535
| – | – | 0.02% | 119 |
|
|
2019
Q1 | $23K | Hold |
535
| – | – | 0.02% | 125 |
|
|
2018
Q4 | $22K | Hold |
535
| – | – | 0.02% | 125 |
|
|
2018
Q3 | $25K | Buy |
535
+160
| +43% | +$7.31K | 0.02% | 123 |
|
|
2018
Q2 | $16K | Sell |
375
-60
| -14% | -$2.8K | 0.01% | 155 |
|
|
2018
Q1 | $20K | Buy |
435
+60
| +16% | +$2.91K | 0.02% | 133 |
|
|
2017
Q4 | $19K | Buy |
+375
| New | +$19.8K | 0.02% | 119 |
|
Other funds holding MET
Centerpoint Advisors's MET Position: Q3 2026 in Review
Centerpoint Advisors increased its MetLife (MET) stake by 50% in Q3 2026, buying an estimated $22.2K and bringing the position to 697 shares worth $66K. The position accounts for 0.02% of the portfolio, ranked #152.
Centerpoint Advisors first reported a position in MET in Q4 2017 and has held it in 36 quarters since. 1,309 funds tracked by Wall St. Rank hold MET as of Q3 2026.
- Centerpoint Advisors held 697 shares of MetLife worth $66K as of Q3 2026.
- Centerpoint Advisors bought 233 MetLife shares in Q3 2026, an estimated $22.2K.
- MetLife made up 0.02% of Centerpoint Advisors's portfolio in Q3 2026, its #152 holding.
- Centerpoint Advisors first reported a position in MetLife in Q4 2017 and has held it in 36 quarters since.
- 1,309 funds tracked by Wall St. Rank held MetLife as of Q3 2026.
Based on Centerpoint Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.